SEC
SlamSEC
SearchBrowseEarnings

DermTech, Inc.

Services-Medical Laboratories·SAN DIEGO, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Revenue
$14.5M
+22.6% YoY
FY 2023
Adj. EBITDA
-$118.0M
-812.5% margin
FY 2023
Net Income
-$116.7M
-803.7% margin
FY 2023
EPS (Diluted)
-$3.88
FY 2023
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$77.8M
FY 2023
Total Debt
$516,000
FY 2019
Net Cash
$77.2M
FY 2019
Enterprise Value
—
Debt / EBITDA
0.7x
FY 2023
EV / EBITDA
—
Employees
—
CFO
Sun Kevin M